Genetically Engineered Biomimetic Nanozymes Reprogram Immune Niches to Intercept Colitis-Carcinoma Transition
Qi Sun, Wanling Liu, Sijie Li, Xiwen Chen, Hanjie Zhang, Dongze Mo, Pinwen Zhou, Xiaomiao Cui, Di Huang, Bing Xia, Jingjing Zhang, Xinying Wang, Xiaoyu Wang, Hui Wei
This paper develops genetically engineered nanozymes that target immune niches to prevent colitis-associated colorectal cancer by reducing oxidative stress and immune cell infiltration.
bioRxiv · Mar 16, 2026 · PreprintBioengineering